Yaping Xu
-
- Lung Cancer Diagnosis and Treatment 17
- Lung Cancer Treatments and Mutations 13
- Gastric Cancer Management and Outcomes 5
- Oncology top 10%
- Lung Cancer Research Studies 6
- Cancer Immunotherapy and Biomarkers 4
-
- Radiomics and Machine Learning in Medical Imaging 5
-
- Esophageal Cancer Research and Treatment 8
- Tissue Engineering and Regenerative Medicine 3
- Co-authors
- Fei ZhouQinghua XuTao JiangXuefei LiHui LiuCaicun ZhouWeimin MaoXiaojiang Sun
- Journals
- Journal of Clinical Oncology (9 papers)Translational Lung Cancer Research (5 papers)Annals of Translational Medicine (3 papers)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Yaping Xu
39 papers receiving 520 citations
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 358
- Oncology 236
- Otorhinolaryngology 19
- Radiology, Nuclear Medicine and Imaging 76
- Cancer Research 47
Countries citing papers authored by Yaping Xu
This map shows the geographic impact of Yaping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Xu more than expected).
Fields of papers citing papers by Yaping Xu
This network shows the impact of papers produced by Yaping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Xu. The network helps show where Yaping Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yaping Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 16 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 27 | |
| 15 | 2020 | 12 | |
| 16 | 2020 | 12 | |
| 17 | 2020 | 29 | |
| 18 | 2020 | 5 | |
| 19 | 2014 | 16 | |
| 20 | 2003 | 15 |
About Yaping Xu
Yaping Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 44 papers that have together received 523 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (13 papers), Esophageal Cancer Research and Treatment (8 papers), Lung Cancer Research Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (358 citations), Oncology (236 citations) and Otorhinolaryngology (19 citations). Yaping Xu has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Fei Zhou, Qinghua Xu, Tao Jiang, Xuefei Li, Hui Liu, Caicun Zhou, Weimin Mao, Xiaojiang Sun, Hui Liu and Fangjuan Li. Their work appears in journals such as Journal of Clinical Oncology, Translational Lung Cancer Research, Annals of Translational Medicine, Frontiers in Oncology and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.